Detalhe da pesquisa
1.
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial.
Diabetologia
; 67(5): 811-821, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38369573
2.
Fluticasone Propionate Orally Disintegrating Tablet (APT-1011) for Eosinophilic Esophagitis: Randomized Controlled Trial.
Clin Gastroenterol Hepatol
; 20(11): 2485-2494.e15, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35181572
3.
Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II).
Gut
; 68(1): 40-48, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29247068
4.
Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis.
Clin Gastroenterol Hepatol
; 17(8): 1477-1488.e10, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30476587
5.
Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study.
Gut
; 64(6): 894-900, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25567115
6.
Plecanatide, an oral guanylate cyclase C agonist acting locally in the gastrointestinal tract, is safe and well-tolerated in single doses.
Dig Dis Sci
; 58(9): 2580-6, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23625291
7.
Pharmacodynamics and safety of pantoprazole in neonates, preterm infants, and infants aged 1 through 11 months with a clinical diagnosis of gastroesophageal reflux disease.
Dig Dis Sci
; 56(2): 425-34, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20607405
8.
Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a placebo-controlled treatment-withdrawal study in infants 1-11 months old with symptomatic GERD.
J Pediatr Gastroenterol Nutr
; 50(6): 609-18, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20400912
9.
Single-dose, multiple-dose, and population pharmacokinetics of pantoprazole in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD).
Eur J Clin Pharmacol
; 66(6): 555-61, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20306184
10.
Effect of Food Intake and Body Position on the Pharmacokinetics of Swallowed APT-1011, a Fluticasone Orally Disintegrating Tablet, in Healthy Adult Volunteers.
J Clin Pharmacol
; 60(6): 734-743, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31943257
11.
Randomised clinical trial: the safety and tolerability of fluticasone propionate orally disintegrating tablets versus placebo for eosinophilic oesophagitis.
Aliment Pharmacol Ther
; 51(8): 750-759, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32149424
12.
Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating ß7+ T Cells in Crohn's Disease: Report of the TOSCA Study.
J Crohns Colitis
; 12(2): 188-196, 2018 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961770
13.
Multicenter, randomized, double-blind study comparing 20 and 40 mg of pantoprazole for symptom relief in adolescents (12 to 16 years of age) with gastroesophageal reflux disease (GERD).
Clin Pediatr (Phila)
; 45(8): 741-9, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16968960
14.
Editorial: fluticasone propionate orally disintegrating tablets-interesting concept but is it going anywhere? Authors' reply.
Aliment Pharmacol Ther
; 51(10): 990-991, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32338781
15.
Gastrointestinal tolerance of a new infant milk formula in healthy babies: an international study conducted in 17 countries.
Nutrition
; 18(6): 484-9, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12044821
16.
Effect of supplementing a high-fat, low-carbohydrate enteral formula in COPD patients.
Nutrition
; 19(3): 229-32, 2003 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12620524
17.
Effect of oral supplementation on catch-up growth in picky eaters.
Clin Pediatr (Phila)
; 42(3): 209-17, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12739919
18.
Anti-IL21 receptor monoclonal antibody (ATR-107): Safety, pharmacokinetics, and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study.
J Clin Pharmacol
; 54(1): 14-22, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23913720
19.
Randomized, open-label, multicentre pharmacokinetic studies of two dose levels of pantoprazole granules in infants and children aged 1 month through <6 years with gastro-oesophageal reflux disease.
Clin Pharmacokinet
; 50(8): 541-50, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21740077
20.
A multicenter, randomized, open-label, pharmacokinetics and safety study of pantoprazole tablets in children and adolescents aged 6 through 16 years with gastroesophageal reflux disease.
J Clin Pharmacol
; 51(6): 876-87, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20852004